Vaccine Update Newsletter Archive
Vaccine Resources: Lots of New and Updated Resources
Check out the list of resources from the CDC and AAP, including interim recommendations for use of nirsevimab during the current shortage and updated Red Book chapter on use of PCV20.
On the Bookshelf: "Guidelines for the Governance of Digital Platforms"
Published by UNESCO, this report presents five principles for governing digital platforms moving forward. Check it out!
Technically Speaking — Federal Documents to Assist In Informed Consent: Required Or Not, Here They Come!
Find general requirements for informed consent before vaccination and specific requirements for COVID-19 and RSV.
In the Journals: Adenovirus and VITT
Vaccine-induced thrombotic thrombocytopenia (VITT) has been shown to follow vaccination with COVID-19 adenovirus vector vaccines. Now, two research studies have shown that VITT also follows adenovirus infection. Find out more.
News & Views: Vaccines — Local? Societal? Both.
Find out how societal protection is at the mercy of local protection, and access multiple reports about local, national and global vaccine coverage.
Vaccine Resources: CDC Training Opportunities, NFID Resource Library, and NRC-RIM Needs Assessment Toolkit
Find info about CDC's training programs, NFID's resource library, and NRC-RIM's health needs assessment toolkit.
On the Bookshelf: Environmental Scan Report Highlights COVID-19 Vaccination and Testing Best Practices
Find more about an environmental scan that highlighted successes and challenges encountered during implementation of COVID-19 vaccination and testing programs.
Technically Speaking: New Online Modules for Clinicians and Caregivers
Find a summary of VEC's free online modules aimed at keeping providers up to date on the latest vaccination practices.
In the Journals: Treating the Different Stages of COVID-19
Check out the findings of a study that evaluated the effects of a topical steroid (fluticasone) on the progression of COVID-19 disease.
News & Views — Implementing RSV Protection for Babies: Answering the Who? What? Where? When? Why? and How?
Have you implemented nirsevimab in your practice? Do you have questions about how to do so? Check out some key concepts and best practices.